Information Provided By: 
Fly News Breaks for November 12, 2018
ATHN
Nov 12, 2018 | 09:37 EDT
KeyBanc analyst Donald Hooker lowered his price target for Athenahealth to $142 from $170 given his reduced 2019 outlook. The analyst notes that the company's Board of Directors continues to evaluate strategic alternatives to potentially sell it to a third-party organization. In the meantime, Hooker says that new business development has remained weak with Q3 bookings down 20%-plus year over year. He reiterates an Overweight rating on the shares.
News For ATHN From the Last 2 Days
There are no results for your query ATHN
